Osteoporosis affects an estimated 200 million women worldwide, and one in three women over 50 will experience an osteoporotic fracture in her lifetime (IOF, 2022). Yet public health messaging around bone health has been dominated by a single message — "drink more milk, get more calcium" — that fundamentally misrepresents the complexity of bone metabolism. Large prospective studies, including the Harvard Nurses' Health Study (Feskanich et al., 1997, American Journal of Public Health), found no significant reduction in hip fracture risk among women with high dairy consumption, challenging the calcium-centric narrative.
The reason is straightforward: bone is a living composite material comprising approximately 35% organic matrix (primarily type I collagen, osteocalcin, osteonectin, and other proteins) and 65% mineral phase (predominantly calcium hydroxyapatite crystals deposited on the collagen scaffold). Calcium is just one mineral in that hydroxyapatite lattice. Optimal bone density and quality requires a complete nutritional ecosystem — vitamin D3, vitamin K2, magnesium, boron, phosphorus, protein, and collagen precursors, all interacting synergistically.
The Calcium Myth: Why Calcium Alone Is Not Enough
The Calcium Myth: Why Calcium Alone Is Not Enough
Calcium supplements alone — without cofactors — present a complicated risk-benefit picture. A 2010 meta-analysis by Bolland et al. in the British Medical Journal raised concern that calcium supplementation without vitamin D was associated with a 31% increase in myocardial infarction risk, possibly because unguided calcium absorbed from supplements deposits in arterial walls rather than bone. The missing variable is vitamin K2, which activates matrix Gla protein (MGP) — a potent inhibitor of vascular calcium deposition — and osteocalcin, the hormone that incorporates calcium into bone matrix.
The bone-building cycle, simplified:
- Vitamin D3 stimulates calcium absorption in the intestine (via calbindin synthesis) and raises serum calcium
- Vitamin K2 activates osteocalcin (carboxylation at glutamic acid residues), allowing it to bind calcium and mineralize bone matrix
- Vitamin K2 simultaneously activates MGP, inhibiting calcium from depositing in arteries, kidneys, and soft tissues
- Magnesium is required for vitamin D activation (hydroxylation in liver and kidney) and directly regulates osteoblast/osteoclast activity
- Calcium then mineralizes the collagen scaffold — which itself requires adequate protein, vitamin C, and copper for synthesis
Remove any one of these cofactors, and the system is compromised. High calcium intake without vitamin K2 may increase calcium exposure to arteries while doing little to increase bone mineral density.
Vitamin D3: The Calcium Absorption Orchestrator
Vitamin D3: The Calcium Absorption Orchestrator
Vitamin D3 (cholecalciferol) is produced in the skin via UV-B photolysis of 7-dehydrocholesterol. Its bioactive form, 1,25-dihydroxyvitamin D (calcitriol), acts as a steroid hormone — binding to nuclear vitamin D receptors (VDR) in intestinal enterocytes and stimulating transcription of calcium transport proteins (calbindin-D9k and TRPV6). This mechanism is responsible for approximately 60–80% of intestinal calcium absorption efficiency.
At vitamin D sufficiency (serum 25-OH-D ≥ 50 nmol/L), intestinal calcium absorption efficiency is approximately 30–40%. At deficiency levels (below 25 nmol/L), it falls to as low as 10–15% — meaning more than twice as much dietary calcium is required to achieve the same absorbed dose. Vitamin D deficiency affects an estimated 1 billion people globally, making it among the most prevalent nutritional deficiencies worldwide.
Key vitamin D guidance for bone health:
- Target serum 25-OH-D: 75–125 nmol/L (30–50 ng/mL) for bone-specific benefits
- Supplementation dose: 1000–4000 IU/day of D3 for most deficient adults (higher in obese individuals due to sequestration in adipose tissue)
- Food sources: Fatty fish, egg yolks, fortified dairy — but dietary sources alone rarely achieve sufficiency without sun exposure or supplementation
- Take with fat: Vitamin D3 is fat-soluble; absorption increases by 32% when taken with a fatty meal
Vitamin K2: Directing Calcium Where It Belongs
Vitamin K2: Directing Calcium Where It Belongs
Vitamin K exists in two primary dietary forms: K1 (phylloquinone, from leafy greens) and K2 (menaquinones, primarily MK-4 from animal fats and MK-7 from fermented foods). For bone and cardiovascular health, K2 — particularly the long-chain MK-7 form with its 3-day half-life — is most relevant.
Osteocalcin, the most abundant non-collagen protein in bone, requires carboxylation by vitamin K2-dependent gamma-carboxylase enzyme to bind calcium hydroxyapatite crystals. Studies show that supplementation with 180 mcg/day of MK-7 significantly reduced undercarboxylated osteocalcin (ucOC) — a marker of functional K2 sufficiency — and improved bone strength indices at the femoral neck in a 3-year RCT in postmenopausal women (Knapen et al., 2013, Osteoporosis International).
Best dietary sources of K2:
- Natto (fermented soybeans): 850–1000 mcg MK-7 per 100g — by far the richest source; a single 30–50 g serving provides multiple weeks' worth of MK-7
- Aged hard cheeses: Gouda, Brie, and Jarlsberg contain 50–75 mcg MK-8/MK-9 per 100g
- Egg yolks: Approximately 15–20 mcg MK-4 per yolk from pasture-raised chickens
- Chicken liver: Rich in MK-4; approximately 12–15 mcg per 100g serving
Magnesium: The Overlooked Bone Mineral
Magnesium: The Overlooked Bone Mineral
Approximately 60% of the body's total magnesium is stored in bone — both as a structural component of hydroxyapatite and as a surface-level pool available for rapid mobilization during blood magnesium homeostasis. Magnesium serves bone health through three critical mechanisms:
- Vitamin D activation: Magnesium is a cofactor for both hepatic 25-hydroxylase and renal 1-alpha-hydroxylase enzymes that activate vitamin D. Magnesium deficiency impairs vitamin D conversion, meaning supplementing vitamin D without adequate magnesium may be less effective than expected (Uwitonze & Razzaque, 2018, Journal of the American Osteopathic Association).
- PTH regulation: Magnesium is required for parathyroid hormone (PTH) secretion and for peripheral tissue response to PTH. Hypomagnesemia impairs PTH function, potentially dysregulating the calcium-phosphate balance that drives bone remodeling.
- Osteoblast and osteoclast activity: Magnesium ions influence cell-matrix adhesion in osteoblasts (bone-building cells) and modulate RANKL/OPG signaling pathways that regulate osteoclast (bone-resorbing cell) differentiation and activity.
The dietary reference intake for magnesium is 310–320 mg/day for adult women and 400–420 mg/day for adult men — yet surveys consistently find 50–70% of adults fall short. Best dietary sources: pumpkin seeds (37% DV per 28g), dark leafy greens (spinach: 20% DV per 100g cooked), dark chocolate (16% DV per 28g), legumes, and whole grains.
Boron, Collagen, and Protein: The Structural Framework
Boron, Collagen, and Protein: The Structural Framework
Boron
Boron is a trace mineral with increasing evidence for bone-health relevance. Boron deprivation studies in postmenopausal women show increased urinary calcium and magnesium excretion and depressed serum 17-beta estradiol and testosterone — both sex hormones that maintain bone density. Supplementation with 3 mg/day of boron reversed these changes in the landmark study by Nielsen et al. (1987, FASEB Journal). Boron appears to stabilize the half-life of vitamin D and estrogen, acting as a nutritional amplifier for both. Best dietary sources: avocado, prunes, raisins, almonds, and legumes.
Collagen Peptides
The organic matrix of bone is 90% type I collagen, which provides the tensile scaffold onto which mineral crystals are deposited. Without adequate collagen quality, bones become brittle (as seen in osteogenesis imperfecta). Hydrolyzed collagen peptides have been shown in a 12-month RCT (König et al., 2018, Nutrients) to increase bone mineral density at the spine and femoral neck by approximately 1.5–2% versus placebo in postmenopausal women. Dosing used was 5 g/day of specific collagen peptides. Vitamin C is an essential co-factor for collagen synthesis (hydroxylation of proline and lysine by prolyl and lysyl hydroxylases).
Dietary Protein
Adequate protein is essential for IGF-1 production — the primary growth factor stimulating osteoblast proliferation and activity. Low protein intake is associated with reduced bone mineral density and increased hip fracture risk in epidemiological studies. Current bone-health-optimized protein targets are 1.2–1.6 g/kg/day for older adults, with emerging evidence that leucine-rich proteins (dairy, eggs, legumes) specifically stimulate osteoblast mTORC1 signaling.
Complete Bone Nutrition: Nutrient Reference Table
Complete Bone Nutrition: Nutrient Reference Table
| Nutrient | Primary Bone Role | Recommended Daily Target | Best Food Sources | Key Interaction |
|---|---|---|---|---|
| Calcium | Hydroxyapatite mineral | 1000–1200 mg (adults) | Dairy, fortified plant milk, sardines with bones, kale | Requires D3 + K2 for proper deposition |
| Vitamin D3 | Intestinal calcium absorption (60–80%) | 1000–4000 IU/day; serum target 75–125 nmol/L | Fatty fish, egg yolk, fortified foods, sunlight | Requires magnesium for activation |
| Vitamin K2 (MK-7) | Osteocalcin carboxylation, MGP activation | 90–180 mcg/day | Natto, aged cheese, egg yolk, chicken liver | Works synergistically with D3 |
| Magnesium | D3 activation, PTH regulation, bone mineral | 310–420 mg/day | Pumpkin seeds, spinach, dark chocolate, legumes | Required for D3 conversion |
| Boron | D3 and estrogen half-life extension | 3 mg/day | Avocado, prunes, almonds, raisins | Amplifies vitamin D and sex hormone effects |
| Collagen Peptides | Organic matrix scaffold quality | 5–10 g/day (hydrolyzed) | Bone broth, supplement | Requires vitamin C for synthesis |
| Protein | IGF-1 stimulation, osteoblast function | 1.2–1.6 g/kg/day | Dairy, eggs, legumes, fish, lean meat | Leucine-rich sources amplify mTORC1 in osteoblasts |
| Vitamin C | Collagen hydroxylation (proline, lysine) | 75–90 mg/day (500+ for collagen support) | Bell peppers, kiwi, citrus, broccoli | Essential co-factor for type I collagen synthesis |
Lifestyle Factors and NIR Light as a Complementary Bone Wellness Tool
Lifestyle Factors and NIR Light as a Complementary Bone Wellness Tool
Nutrition provides the molecular building blocks for bone, but bone formation is also a mechanically-driven process. Wolff's Law states that bone density adapts to the mechanical loads placed upon it — meaning weight-bearing exercise is an irreplaceable stimulus for bone remodeling. Resistance training (3+ sessions per week with progressive overload) and high-impact activity (walking, jogging, jumping) generate the mechanical strain signals that activate osteocyte mechanosensing pathways, ultimately increasing osteoblast activity and bone mineral density.
This has practical implications for NIR light as a wellness complement: the periosteum, bone marrow, and surrounding musculature all contain mitochondria-rich cells that can absorb 850 nm photons. Animal studies on photobiomodulation and bone have demonstrated enhanced osteoblast proliferation and mineralization in vitro, and accelerated fracture healing in rodent models (de Medeiros et al., 2017, Lasers in Medical Science). While the CIRIUS device is not indicated for treating osteoporosis, using NIR light to support muscle function and local circulation around load-bearing joints — hips, knees, lumbar spine — creates a musculoskeletal environment where weight-bearing exercise is more comfortable and sustainable, indirectly supporting the mechanical stimulus that bones need.
Additional lifestyle factors with documented bone health impact:
- Avoid smoking: Nicotine reduces osteoblast function and is associated with up to 25% lower bone mineral density in smokers versus non-smokers
- Moderate alcohol: Chronic heavy alcohol intake suppresses osteoblastogenesis and inhibits calcium absorption; moderate consumption (1 drink/day or less) has minimal impact
- Assess medications: Proton pump inhibitors (PPIs), corticosteroids, and certain anticonvulsants interfere with calcium and vitamin D metabolism — discuss bone health monitoring with your physician if you take these long-term


